Edwards Lifesciences (NYSE:EW) Price Target Lowered to $70.00 at Evercore ISI
Edwards Lifesciences (NYSE:EW – Free Report) had its price target reduced by Evercore ISI from $76.00 to $70.00 in a research note published on Tuesday, Benzinga reports. They currently have an in-line rating on the medical research company’s stock. Several other research analysts have also commented on the company. Bank of America lowered Edwards Lifesciences […]
5 Oct 18:25 · The Cerbat Gem